Protalix BioTherapeutics
PLX
#8879
Rank
C$0.23 B
Marketcap
C$2.96
Share price
1.90%
Change (1 day)
37.19%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): C$10.47 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$61.84 Million. In 2024 the company made an earning of C$7.2 Million a decrease over its 2023 earnings that were of C$16.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$10.47 M45.45%
2024 C$7.2 M-55.62%
2023 C$16.23 M-199.05%
2022 -C$16.39 Million-40.38%
2021 -C$27.49 Million-732.31%
2020 C$4.34 M-130.53%
2019 -C$14.24 Million189.85%
2018 -C$4.92 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$25.57 Million-32.37%
2015 -C$37.81 Million10.11%
2014 -C$34.34 Million-7.59%
2013 -C$37.15 Million
2011 -C$43.02 Million-19.39%
2010 -C$53.37 Million20.87%
2009 -C$44.16 Million32.26%
2008 -C$33.39 Million-5.46%
2007 -C$35.31 Million
2004 -C$0.23 Million12.35%
2003 -C$0.21 Million-11.1%
2002 -C$0.23 Million-57.03%
2001 -C$0.54 Million1.03%
2000 -C$0.53 Million-53.22%
1999 -C$1.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.62 B 141,889.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.10 B 10,609.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.13 B 30,346.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel